Skip to content

Thunder Bay

Thunder Bay’s Bombardier lands $60-million contract (10/03)

Bombardier Inc. has received $60-million contract to manufacture 22 commuter rail cars for the Montreal transit authority.

Timmins-based IT training project advances (9/03)

A program for information technology training in Northern Ontario is starting to move ahead.

Staging shows in-house (8/03)

By IAN ROSS For Lyle Knudsen, staging trade shows is about building and cementing relationships. “I sometimes shake my head when I walk through trade shows,” says the vice-president of Equipment World.

Hebert to lead special projects (8/03)

Larry Hebert of Thunder Bay Hydro has been appointed to position of special projects manager of the company, a shift from the 20 plus years he served as general manager.

Synfuel moves on $230M power plant (8/03)

By KELLY LOUISEIZE Groundbreaking to develop a $230-million power plant on Fort William First Nation in Thunder Bay may get underway early 2004.

Industrial park attracts interest (7/03)

By ANDREW WAREING Hockey, new infrastructure and new industry promises to offer Fort William First Nation a hat trick in future prosperity.

Bug battle prompts new idea for entrepreneur (7/03)

By KELLY LOUISEIZE It takes a certain entrepreneurial spirit to visualize opportunity out of mayhem. That is what Maurice Bedard of Kenora has done.

Training centre to be developed (7/03)

BY SCOTT HUNTER HADDOW The City of Dryden and the surrounding area is about to reap the benefits of the will and determination of community members melding together to create a new, state-of-the-art Training and Cultural Auditorium Centre.

Seminar draws ideas of value (7/03)

By IAN ROSS Canadians have manufactured a centuries-old reputation as hewers of wood and drawers of water, exporting rail-car loads and ship loads of raw material for someone else to process into consumer goods. But the ongoing Canada-U.S.

Cancer detection focus of study (6/03)

By KELLY LOUISEIZE Scientists at Genesis Genomics are studying over 300 prostate cancer patients for the purpose of targeting non-nuclear DNA for early detection of cancer.